Organogenesis Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Organogenesis Holdings using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0.18 | $0.07 | 152.9 % |
| Q2 | 2025-08-07 | $-0.06 | $-0.01 | -500.0 % |
| Q1 | 2025-05-08 | $-0.11 | $-0.03 | -253.3 % |
| Q4 | 2025-02-27 | $0.07 | $0.02 | 250.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $150.86M | $134.10M | 12.5 % |
| Q2 | 2025-08-07 | $100.78M | $104.75M | -3.79 % |
| Q1 | 2025-05-08 | $86.70M | $90.77M | -4.48 % |
| Q4 | 2025-02-27 | $126.66M | $109.60M | 15.6 % |
Organogenesis Holdings (ORGO) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $0.18, which beat the estimate of $0.07.
The Actual Revenue was $150.9M, which beat the estimate of $134.1M.
Browse earnings estimates, EPS, and revenue on all stocks.